98 related articles for article (PubMed ID: 387467)
1. Enzyme replacement therapy of lysosome storage disease.
Lloyd JB; Griffiths PA
Front Biol; 1979; 48():517-32. PubMed ID: 387467
[No Abstract] [Full Text] [Related]
2. Prospects for enzyme replacement for lysosomal storage diseases.
Sly WS
Birth Defects Orig Artic Ser; 1981; 17(1):201-13. PubMed ID: 7284581
[No Abstract] [Full Text] [Related]
3. Toward enzyme therapy for lysosomal storage diseases.
Desnick RJ; Thorpe SR; Fiddler MB
Physiol Rev; 1976 Jan; 56(1):57-99. PubMed ID: 813242
[No Abstract] [Full Text] [Related]
4. Enzyme therapy in lysosomal storage diseases: current approaches.
Rattazzi MC
Prog Clin Biol Res; 1982; 103 Pt B():573-87. PubMed ID: 6219401
[No Abstract] [Full Text] [Related]
5. The uptake of enzymes into lysosomes: an overview.
Neufeld EF
Birth Defects Orig Artic Ser; 1980; 16(1):77-84. PubMed ID: 7448363
[TBL] [Abstract][Full Text] [Related]
6. [Pathobiochemical aspects of lysosomal enzymes with special reference to lysosomal storage diseases (author's transl)].
Kresse H
Wien Klin Wochenschr; 1978 May; 90(10):325-32. PubMed ID: 418578
[TBL] [Abstract][Full Text] [Related]
7. Animal models and enzyme immobilization in the development of enzyme replacement therapy: an overview.
Fiddler MB
Birth Defects Orig Artic Ser; 1980; 16(1):143-62. PubMed ID: 7004515
[No Abstract] [Full Text] [Related]
8. Letter: Enzyme-carrier potential of liposomes in enzyme replacement therapy.
Gregoriadis G
N Engl J Med; 1975 Jan; 292(4):215. PubMed ID: 1109221
[No Abstract] [Full Text] [Related]
9. An appraisal of human trials in enzyme replacement therapy of genetic diseases.
Tager JM; Hamers MN; Schram AW; Van den Bergh FA; Rietra PJ; Loonen C; Koster JF; Slee R
Birth Defects Orig Artic Ser; 1980; 16(1):343-59. PubMed ID: 6778527
[No Abstract] [Full Text] [Related]
10. Receptor-mediated uptake of lysosomal enzymes.
Sly WS; Kaplan A; Achord DT; Brot FE; Bell CE
Prog Clin Biol Res; 1978; 23():547-51. PubMed ID: 662919
[TBL] [Abstract][Full Text] [Related]
11. The carrier potential of liposomes in biology and medicine (second of two parts).
Gregoriadis G
N Engl J Med; 1976 Sep; 295(14):765-70. PubMed ID: 785256
[No Abstract] [Full Text] [Related]
12. Treatment of acid phosphatase deficiency disorders.
Nadler HL
Birth Defects Orig Artic Ser; 1973 Mar; 9(2):195-7. PubMed ID: 4139985
[No Abstract] [Full Text] [Related]
13. Replacement therapy for inherited enzyme deficiencies.
Farrow BR
Cornell Vet; 1989 Jul; 79(3):211-6. PubMed ID: 2666022
[No Abstract] [Full Text] [Related]
14. Human trials: direct enzyme replacement--summary and discussion.
Nadler HL
Birth Defects Orig Artic Ser; 1980; 16(1):425-6. PubMed ID: 7004521
[No Abstract] [Full Text] [Related]
15. [Enzyme replacement: recognition and transport of lysosomal enzymes].
González Noriega A
Bol Estud Med Biol; 1983; 32(7-8 Suppl 1):209-17. PubMed ID: 6543638
[No Abstract] [Full Text] [Related]
16. [Intravital determination of pH gradient between the cytoplasm and lysosomes in human fibroblasts in the normal state and in hereditary storage diseases].
Ivleva TS; Ogloblina TA; Litinskaia LL; Khrust IuR; Vidershaĭn GIa
Biull Eksp Biol Med; 1991 May; 111(5):495-8. PubMed ID: 1953901
[TBL] [Abstract][Full Text] [Related]
17. Immobilized enzymes. Their applications in medicine.
Anderson PM; Salo WL
Minn Med; 1973 Dec; 56(12):1036-40. PubMed ID: 4800830
[No Abstract] [Full Text] [Related]
18. Chemical diagnosis of inborn lysosomal storage disorders involving the eye.
Dawson G; Tsay GC
Birth Defects Orig Artic Ser; 1976; 12(3):1-13. PubMed ID: 821555
[No Abstract] [Full Text] [Related]
19. Enzyme therapy in genetic diseases:2.
Birth Defects Orig Artic Ser; 1980; 16(1):1-544. PubMed ID: 7448352
[No Abstract] [Full Text] [Related]
20. Interactions of membranes, microfilaments, and microtubules in endocytosis and exocytosis.
Allison AC; Davies P
Adv Cytopharmacol; 1974; 2():237-48. PubMed ID: 4374057
[No Abstract] [Full Text] [Related]
[Next] [New Search]
